Literature DB >> 20658177

Comparison of the effect of homocysteine and its thiolactone on the fibrinolytic system using human plasma and purified plasminogen.

Joanna Kołodziejczyk1, Joanna Malinowska, Pawel Nowak, Beata Olas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20658177     DOI： 10.1007/s11010-010-0545-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


× No keyword cloud information.
  11 in total

1.  Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection.

Authors:  R Głowacki; K Wójcik; E Bald
Journal:  J Chromatogr A       Date:  2001-04-20       Impact factor: 4.759

2.  Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma.

Authors:  Joanna Malinowska; Paweł Nowak; Beata Olas
Journal:  Thromb Res       Date:  2010-12-24       Impact factor: 3.944

3.  Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia.

Authors:  Derrick L Sauls; Erin K Arnold; Charles W Bell; Jonathan C Allen; Maureane Hoffman
Journal:  Thromb Res       Date:  2006-09-18       Impact factor: 3.944

4.  Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen.

Authors:  Rita Marchi; Zoila Carvajal; John W Weisel
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

5.  Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.

Authors:  T Krajewski; P Nowak; C Cierniewski
Journal:  Acta Biochim Pol       Date:  1985       Impact factor: 2.149

Review 6.  Mechanism of action of homocysteine and its thiolactone in hemostasis system.

Authors:  K Karolczak; B Olas
Journal:  Physiol Res       Date:  2008-11-04       Impact factor: 1.881

7.  Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.

Authors:  Derrick L Sauls; Evelyn Lockhart; Maria Esteban Warren; Angela Lenkowski; Susan E Wilhelm; Maureane Hoffman
Journal:  Biochemistry       Date:  2006-02-28       Impact factor: 3.162

8.  Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.

Authors:  D L Sauls; A S Wolberg; M Hoffman
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

9.  Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.

Authors:  Andrew T Jacovina; Arunkumar B Deora; Qi Ling; M Johan Broekman; Dena Almeida; Caroline B Greenberg; Aaron J Marcus; Jonathan D Smith; Katherine A Hajjar
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

Review 10.  The molecular basis of homocysteine thiolactone-mediated vascular disease.

Authors:  Hieronim Jakubowski
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694
View more
  3 in total

1.  The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients.

Authors:  Magdalena Kedzierska; Joanna Malinowska; Rafal Glowacki; Beata Olas; Edward Bald; Arkadiusz Jeziorski; Janusz Piekarski
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

2.  Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity.

Authors:  Anna Paola Cellai; Donatella Lami; Emilia Antonucci; Agatina Alessandrello Liotta; Angela Rogolino; Sandra Fedi; Claudia Fiorillo; Matteo Becatti; Caterina Cenci; Rossella Marcucci; Rosanna Abbate; Domenico Prisco
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

3.  Subacute combined degeneration of the spinal cord concurrent with acute pulmonary embolism: a case report.

Authors:  Xinyuan Pang; Yulei Hao; Lushun Ma; Lu Liu; Jiachun Feng
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.